Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2
The experimentally established mechanism targets of Hexanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | FABP3 | P05413 | 7/20 | 0.52 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decanoic Acid SCHEMBL580470 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Stearic Acid SCHEMBL840883 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Dodecanoate SCHEMBL19253062 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Palmitic Acid SCHEMBL10396224 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Octanoic Acid SCHEMBL2761867 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Myristic Acid SCHEMBL8588822 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Nonanoate SCHEMBL29370695 | 0.98 | FABP3 (0.55) | CA1FABP3BBOX1CES2CES1 | |
| Decanoic Acid SCHEMBL5318916 | 0.96 | FABP3 (0.53) | CA1FABP3BBOX1CES2CES1 | |
| Myristic Acid SCHEMBL5317287 | 0.96 | FABP3 (0.53) | CA1FABP3BBOX1CES2CES1 | |
| Dodecanoate SCHEMBL5320074 | 0.96 | FABP3 (0.53) | CA1FABP3BBOX1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118058284-A | Fatty acid choline salt soluble solution and preparation method and application thereof | 郑州郑氏化工产品有限公司 | 2024-05-24 | — | — | CN | claimed |
| US-10143969-B2 | Compounds for the capture of carbon dioxide from gaseous mixtures and subsequent release, related process and plant | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2018-12-04 | — | — | US | claimed |
| US-20160346734-A1 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2016-12-01 | — | — | US | claimed |
| EP-3094399-A2 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | Università Degli Studi Di Milano - Bicocca (IT) | 2016-11-23 | — | — | EP | claimed |
| WO-2010136105-A2 | AMMONIUMCARBOXYLATES | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | claimed |
| US-12440438-B2 | Method of remotely controlling pain | Novilla Pharmaceuticals, Inc. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-3503927-B1 | TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT | UNIV CALIFORNIA (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-118058284-A | Fatty acid choline salt soluble solution and preparation method and application thereof | 郑州郑氏化工产品有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-20240156964-A1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE ARIZONA BOARD OF REGENTS | 2024-05-16 | — | — | US | disclosed |
| US-11786597-B2 | Ionic liquids for transdermal drug delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230310528-A1 | DEEP EUTECTIC SOLVENT INCLUDING ONE OR MORE ACTIVE PHARMACEUTICAL INGREDIENTS DERIVED FROM MUSHROOMS | OPTIMI HEALTH CORP (CA) | 2023-10-05 | — | — | US | disclosed |
| US-20230093875-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-03-30 | — | — | US | disclosed |
| EP-3094399-A2 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | Università Degli Studi Di Milano - Bicocca (IT) | 2016-11-23 | — | — | EP | disclosed |
| US-20160263225-A1 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE ARIZONA BOARD OF REGENTS | 2016-09-15 | — | — | US | disclosed |
| EP-3062819-A2 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | The Regents of The University of California (US) | 2016-09-07 | — | — | EP | disclosed |
| WO-2015107416-A3 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | UNIVERSITA DEGLI STUDI DI MILANO-BICOCCA (IT) | 2015-12-10 | — | — | WO | disclosed |
| WO-2015066647-A9 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015066647-A2 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-05-07 | — | — | WO | disclosed |
| WO-2010136105-A2 | AMMONIUMCARBOXYLATES | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | disclosed |
| US-4927728-A | Carrier particles for use in a two-component dry-type developer | RICOH COMPANY, LTD. (JP) | 1990-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10143969-B2 | Compounds for the capture of carbon dioxide from gaseous mixtures and subsequent release, related process and plant | GK, AGXT, GHDC | CA1 34/4885FABP3 294/4885BBOX1 1485/4885 |
| US-20230093875-A1 | IONIC LIQUIDS FOR INTERNAL DELIVERY | PNLIP, LIPA, CEL | CA1 2040/4885FABP3 111/4885BBOX1 4575/4885 |
| US-20160346734-A1 | NOVEL COMPOUNDS FOR THE CAPTURE OF CARBON DIOXIDE FROM GASEOUS MIXTURES AND SUBSEQUENT RELEASE, RELATED PROCESS AND PLANT | GK, AGXT, GHDC | CA1 51/4885FABP3 263/4885BBOX1 1315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.